cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock
YCBD.PRA
YCBD.PRA was delisted on the 5th of May, 2025.
4 hedge funds and large institutions have $210K invested in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 1 reducing their positions, and 1 closing their positions.
20% less funds holding
Funds holding: 5 → 4 (-1)
67% less capital invested
Capital invested by funds: $633K → $210K (-$423K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CD
Chapin Davis
Baltimore,
Maryland
|
-$59.8K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$101 |
YCBD.PRA Hedge Fund Activity: Q3 2023 in Review
4 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) for Q3 2023, worth a combined $210K — down 67% from $633K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of YCBD.PRA and 0 opened new positions — a net loss of 1 holder — while 1 trimmed existing stakes and 0 added.
The largest seller was Chapin Davis, cutting an estimated $59.8K.
- 4 institutional investors held cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock (YCBD.PRA) as of Q3 2023, down from 5 in Q2 2023.
- Funds reported $210K of cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock stock for Q3 2023, down 67% quarter-over-quarter.
- 0 funds opened new cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock positions in Q3 2023 and 1 closed out, a net change of -1 holder.
- The largest cbdMD, Inc. 8.0% Series A Cumulative Convertible Preferred Stock seller in Q3 2023 was Chapin Davis, an estimated $59.8K sold.
Based on aggregated 13F filings for Q3 2023.